Elliott Marshall Antman
机构:Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group · ORCID:0000-0002-0808-9199
发表论文 868 篇 · 总被引 191058 次 · h-index 170
代表论文
- Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes (2023 · JACC. Clinical electrophysiology · 被引 39)
- Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial (2023 · International Journal of Cardiology · 被引 33)
- Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation (2024 · Journal of the American College of Cardiology · 被引 32)
- Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation (2024 · Circulation · 被引 32)
- Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation (2024 · JAMA Cardiology · 被引 31)
- Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis (2024 · JAMA Cardiology · 被引 23)